This article has been updated to include a stock quote.

NEW YORK (GenomeWeb News) – Orchid Cellmark today reported flat fourth-quarter revenues as its profit declined on higher costs for performing DNA testing services.

The Princeton, NJ-based firm brought in revenues of $15 million for the three months ended Dec. 31 compared to revenues of $14.9 million in the fourth quarter of 2006.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.